Leaders gather to discuss commercial space flight's future

Some of the top minds in the commercial space flight industry gathered in College Station on Wednesday for a brainstorming session at Texas A&M.

The first-ever Texas Commercial Space Workshop at A&M's Rudder Tower and Memorial Student Center brought together commercial space company representatives, investors, aerospace experts, faculty and students from around the nation. Organizers said the workshop was designed to promote dialogue about where space technology is boldly going and what preparation the workforce will need.

About 100 people attended the keynote speeches that were kicked off by state Rep. John E. Davis, R-Houston, whose district includes NASA. The speakers likened the growing commercial space flight industry, by which private companies will fly people into space, to that of commercial airlines in the early 20th century.

"We should be constantly working to entice new commercial space companies to come to Texas and to incetivize those already here to grow their existing businesses. Recognizing that this is the direction the industry is headed, the Legislature has taken some preliminary steps to help ensure that Texas remains a leader in the commercial space industry," Davis told the crowd.

Davis also gave the audience an update on three pieces of legislation from the latest session aimed at enticing the growth of the commercial space flight industry in Texas. He said companies now have additional legal protection from noise complaints related to space flights, local municipalities were encouraged through liability reduction to partner with commercial space flight companies at municipal airports, and that the Boca Chica Beach near Brownsville can now be closed off for space launches.

Planetary scientist Alan Stern, CEO of Golden Spike and a former member of Time magazine's 100 most influential people in the world, spoke about how the private sector is growing to fill the void left by declining government support for space programs and humanity's efforts to explore the final frontier.

"What we see is the very earliest stages of the development of the whole span of commercial space systems from suborbital to orbital, transportation systems to destination systems, by a whole variety of different companies," Stern said. "If it's anything like early aviation in the 1920s, there's going to be a lot of failures. There's going to be people who get hurt, just like in aviation. There's going to be people who get killed, just like in aviation. There are going to be companies that fail and companies that succeed.

"But this is the American nation and we know how to overcome failure. I predict that the development of commercial space will have its rough spots, but that by the time we get to the 2020s you will see a change in the way people think about space. I think people will primarily think of it as commercial space."

He also elaborated on his company, Golden Spike, which plans to provide commercial trips to the surface of the moon. The service will be primarily targeted at countries without robust space programs, but will be open to corporations and individuals willing to pay. Stern hopes the company will be offering two to three flights per year by 2020. Each flight will fit two persons and will cost $1.5 billion, he said.

"This system will give us the same capability as early Apollo missions," Stern said. "Two people to the moon on each expedition for two days at a time, each one conducting two space walks just like Neil [Armstrong] and Buzz [Aldrin]. They will be able to conduct field geology, sampling, bringing samples home to conduct experiments. I'm a planetary scientist, this is mouth-watering stuff."

View post:

Leaders gather to discuss commercial space flight's future

Government Shutdown Threatens Future NASA Missions

NASA celebrated its 55th anniversary by shuttering websites and furloughing most of its 18 000 employees as a U.S. government shutdown took effect on 1 October. But future space exploration missions stand to suffer the most from the shutdown's impact.

The U.S. space agency will likely halt work on satellites or spacecraft that have yet to launch, according to NASA's shutdown plans detailed bySPACE.com. Phil Plait, creator of Bad Astronomy, points out that the shutdown could delay the upcoming Mars MAVEN mission beyond its scheduled launch on 18 November and possibly push the mission back until 2016the next time when Mars and the Earth will be aligned in the best positions for the spacecraft to reach the red planet.

A skeleton crew of mission controllers in Houston continues to support the six members of the International Space Station, including two NASA astronauts, an Italian astronaut, and three Russian cosmonauts. But an astounding 97 percent of NASA's approximately 18 134 employees won't work during the government shutdown.

Still, NASA's shutdown plan includes measures tomaintain existing satellites and spacecraft such as the Hubble Space Telescope and the recently-launched LADEE lunar probe, even if the agency will put scientific measurements and photo collection on hold.

"The extent of support necessary and the time needed to safely cease project activities will depend on whether any of the activities are of a hazardous nature (e.g., parts of the satellite may need to be cooled)," according to NASA's shutdown plan.

Perhaps the most public sign of NASA's shutdown is the sudden silence from NASA's many active social media accounts on Twitter, Facebook, and elsewhere. NASA TV has gone offline, and visitors to theNASA.govwebsite are greeted with the message: "Due to the lapse in federal government funding, this website is not available."

Not every space mission has gone into immediate shutdown mode. NASA missions operated by private contractorssuch as the California Institute of Technology's Jet Propulsion Laboratory and Johns Hopkins University's Applied Physics Laboratorywill continue normal operations for the rest of the week, according to aPlanetary Society blog post.

The Jet Propulsion Laboratory covers a wide range of missions such as the Mars Curiosity and Opportunity rovers, Mars Odyssey, Mars Reconnaissance Orbiter, the Cassini spacecraft exploring the moons of Saturn, the Dawn spacecraft sent to investigate two asteroids, the Voyager 1 spacecraft roaming interstellar space and more. The Applied Physics Laboratory covers the MESSENGER mission orbiting Mercury and the New Horizons spacecraft headed for Pluto.

But JPL and APL spokespersons told the Planetary Society that their facilities would still have to conserve existing funding to keep operating beyond the shutdowntaking it week by week until the U.S. Congress can pass a spending bill that can put NASA back on course.

IEEE Spectrums general technology blog, featuring news, analysis, and opinions about engineering, consumer electronics, and technology and society, from the editorial staff and freelance contributors.

See original here:

Government Shutdown Threatens Future NASA Missions

Nanovations Wins Nanotechnology Supply Contract for Tallest Building in Baku

Sydney Frenchs Forest, NSW, Australia (PRWEB) October 02, 2013

Nanotechnology product manufacturer Nanovations Pty Ltd, announces it has won the contract for the supply of its glass coatings to the Socar Tower project in Baku, Azerbaijan.

The Socar Tower at 209 meters is the highest building in the Caucasus region. The extraordinary skyscraper, in the shape of a burning flame, the signature image of Azerbaijan, comes from the drawing boards of the South Korean architectural firm Heerim Architects and Planners Co Ltd.

Baku is the capital city of the 'Land of Fire', Azerbaijan, and is routinely blasted by strong winds and seismic activity. To resist these challenging conditions, the building can withstand wind speeds of 190 kilometers per hour and is resistant to earthquake measuring 9 on the Richter scale. The tower is build by Turkish Tekfen Construction and Installation Co. Inc.

The highly engineered curtain wall elements of the building are manufactured by Permasteelisa Group, in its new factory complex in Baku. The Permasteelisa Group is the world leader in the design, production and installation of architectural envelopes and curtain walls.

To protect the surface of the outer glass from the elements, and to provide an easy to clean surface, it was decided to coat the glass of the curtain wall panels with the Nanovations NG-1314 coating.

Prior to using the coating, intensive performance testing was conducted at glass laboratories in Europe. The results showed the superior performance of Nanovations products, which lead to Nanovations winning the contract.

In cooperation with Permasteelisa, Nanovations has setup a coating application unit in Baku, with a team of trained and certified applicators that meets the high standards of the Permasteelisa Group.

This partnership has benefited both companies and they believe that the use of the technology in Azerbaijan and beyond, will also have benefits for future projects.

Nanovations durable and effective solutions have been used particularly in buildings and automotive and marine related applications by professional applicators and glass processing firms. The first high rise building, in the world was treated with glass coating solutions from Nanovations.

Read this article:

Nanovations Wins Nanotechnology Supply Contract for Tallest Building in Baku

Research and Markets: European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Report 2013-2017

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fh46g5/european_nuclear) has announced the addition of the "European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Report 2013-2017" report to their offering.

The European stable isotopes market was valued at close to $25.0 million in 2012, and is estimated to grow at a CAGR of more than 8.0% by 2017.

The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 50% to the European revenue.

Radiopharmaceuticals are drugs that contain radionuclide-emitting ionizing radiation and are used for disease diagnosis and treatment. They provide better understanding of diseases as they not only give anatomical but also functional information about the organ. Radiopharmaceuticals are also used in the nuclear imaging field as tracers. They are mostly used for diagnosis with the use of gamma cameras for imaging techniques such as in SPECT and PET. Radioisotopes are majorly used in medical applications with more than 90% share. The medical application is being driven by the increasing patient population and new and effective radioisotopes. The most commonly used isotopes for diagnosis are Tc-99m and Tl-201 for SPECT and F-18 for PET.

The radiopharmaceuticals market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 83% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium-201(Tl-201), gallium-67 (Ga-67) and iodine-123 (I-123). SPECT is majorly used in the diagnosis of cardiac diseases; it is poised to grow at a CAGR of about 7.0% from 2012 to 2017. The PET radioisotopes market is majorly dominated by fluorine-18 (F-18).

Segments in the therapeutic market include beta emitters, brachytherapy isotopes, and alpha emitters. Quantitative information about alpha emitters is not conclusive, as they have not been commercialized; recent clinical studies have, however, showcased immense potential of alpha isotopes in therapies. Beta emitters contribute the highest to the therapy market, dominated by iodine-131(I-153), which is poised to grow at a CAGR of 4.5% from 2012 to 2017. The market is driven by its applications for thyroid cancer, hyperthyroidism, and non-Hodgkin's lymphoma. Significant isotopes in the brachytherapy market are cesium-131(Cs-131), iodine-125 (I-125), palladium-103 (Pd-103), and iridium-192 (Ir-192). Germany is the major market for brachytherapy in terms of market share, followed by France.

The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.

Germany accounted for the largest market share of the European nuclear medicine market, followed by France in 2012. Major players in the radiopharmaceuticals market are Covidien, Plc, GE Healthcare, IBA Group, Lantheus Medical Imaging, Inc., Nordion, Inc., and Siemens Healthcare (PETNET).

Key Topics Covered:

See original here:

Research and Markets: European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Report 2013-2017

Personalized Medicine Roadmap: Definiens Releases Five Steps to Utilize Data Mining with Image Analysis

MUNICH & CARLSBAD, Calif.--(BUSINESS WIRE)--

Definiens, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, today released tips for integrating data mining with image analysis. As pathologists, researchers and clinicians seek to advance personalized medicine through the development and prescription of targeted therapies, data generated through image analysis of digitized tissue sections is becoming essential to stratifying patients and providing personalized care.

With the increasing prevalence and need for personalized medicine, the importance of tissue datafication through image analysis is becoming ever more present. While genomic data is highly valuable, it will be the correlation of genomics and tissue phenomics with patient outcomes that brings a level of accuracy to diagnosis, prognosis, and therapy that cant be met with genomic data alone, says Thomas Heydler, CEO of Definiens.

Definiens five steps for researchers and clinicians to effectively utilize data mining with tissue image analysis include:

For more information on Definiens, visit http://www.Definiens.com.

About Definiens

Definiens is the leading provider of image analysis and data mining solutions for life science, tissue diagnostics, and clinical digital pathology. Definiens' technology provides detailed biomarker readouts from whole slide images and enables the correlation of this information with other key clinical or genomic data. Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and support better decisions in research, diagnostics and therapy.

Definiens vision is to open new fields of research, to contribute to development of personalized medicine, and to significantly improve the quality of patients' lives. Definiens is headquartered in Munich, Germany and has its North American headquarters in Carlsbad, CA. Further information is available at http://www.definiens.com.

Read more:

Personalized Medicine Roadmap: Definiens Releases Five Steps to Utilize Data Mining with Image Analysis